Up, Up, and Away
A business analyst rated Baxter stock a strong BUY, as the PD market has an attractive growth rate in the range of 5% to 6%, and the option is flexible and allows a more normal life.
Read the full article » | Posted 07-14-2017
- Aetna And Fresenius Medical Care North America Partner to Treat ESRD Patients Posted 05-14-2021
- Fresenius Expands NxStage and Nx2me Agreement with DaVita Posted 04-16-2021
- Fresenius Partners with Descartes to Improve Home Dialysis Supply Delivery Posted 03-09-2021
- Fresenius Fleet Management Solution Supports Home Dialysis Growth Posted 02-09-2021